Confronting the hidden face of progesterone during the follicular phase

Journal of Assisted Reproduction and Genetics

Volumn 20, Issue 1, 2003, Pages 29-32

  De Ziegler, Dominique ^a   Brioschi, Pierre Alain ^a   Fanchin, Renato ^a   Bulletti, Carlo ^b  

^a Groupement Hospitalier de l'Ouest Lemanique   (Switzerland)

^b Hospital of Rimini   (Italy)

Author keywords

CAH; COH; Follicular phase; Progesterone

Indexed keywords

ANDROGEN; ESTRADIOL; FOLLITROPIN; PROGESTERONE; STEROID 17ALPHA MONOOXYGENASE; STEROID 21 MONOOXYGENASE;

ACNE; ANDROGEN SYNTHESIS; CONGENITAL ADRENAL HYPERPLASIA; ENZYME BLOOD LEVEL; ENZYME DEFICIENCY; ENZYME SYNTHESIS; ESTROGEN SYNTHESIS; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; ONSET AGE; OVARY; OVARY HYPERSTIMULATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; REVIEW; VIRILIZATION;

ADRENAL HYPERPLASIA, CONGENITAL; FEMALE; FOLLICULAR PHASE; HUMANS; PROGESTERONE; SUPEROVULATION;

EID: 0037277659     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021258721796     Document Type: Review

References (22)

1. Ferenczy A, Bertrand G, Gelfand MM: Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979;133:859-867
2. Ayoubi JM, Brioschi PA, Fanchin R, Epiney M, Campana A, de Ziegler D. Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in vitro fertilization cycle. Fertil Steril, in press.
3. Levran D, Ben-Shlomo I, Pariente C, Dor J, Mashiach S, Weisman A. Famillial partial 17,20 desmolase and 17-hydroxylase deficiency presenting as infertility. J Assit Reprod Genet, in Press.
4. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563-566
5. Mio Y, Sekijima A, Iwabe T Onohara Y, Harada T, Terakawa N. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992;58:159-166
6. Dirnfeld M, Goldman S, Gonen Y, Koifman M, Lissak A, Abramovici H. A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993;10:126-129
7. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090-1094
8. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797-803
9. Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011-1017
10. Hofmann GE, Khoury J, Johnson CA, Thie J, Scott RT Jr. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 1996;66:980-986
11. Abuzeid MI, Sasy MA. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril 1996;65:981-985
12. Lindheim SR, Cohen MA, Chang PL, Sauer MV. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet 1999;16:242-246
13. Fanchin R, Righini C, Olivennes F, de Ziegler D, Selva J, Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 1996;65:1178-1183
14. Fanchin R, Righini C, Olivennes F, Ferreira AL, de Ziegler D, Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: Insights into a controversy. Fertil Steril 1997;68:799-805
15. Adonakis G, Deshpande N, Yates RW, Fleming R. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone. Fertil Steril 1998;69:450-453
16. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, Pocognoli P. Luteinizing hormone activity supplementation enhances follicle - stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659-2663
17. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 2002;87:1156-1161
18. White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-291
19. Chetkowski RJ, DeFazio J, Shamonki I, Judd HL, Chang RJ. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 1984;58:595-598
20. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999;84:960-966
21. Knochenhauer ES, Cortet-Rudelli C, Cunningham RD, Conway BA, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 1997;82:479-485
22. Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med 1997;62:151-158